Patents by Inventor Sang Baie Shin

Sang Baie Shin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230190523
    Abstract: The present invention provides a wirelessly driven contact lens including a strain sensor capable of detecting an increase in intraocular pressure in real time and a drug reservoir capable of lowering the intraocular pressure by releasing a drug based on the increase in intraocular pressure. In the present invention, there may be provided a personal therapy system that measures intraocular pressure in real time and properly releases a therapeutic drug according to the intraocular pressure that is measured through the strain sensor and the drug reservoir for releasing a drug based on an intraocular pressure state of a glaucoma patient.
    Type: Application
    Filed: September 4, 2020
    Publication date: June 22, 2023
    Inventors: Sei Kwang Hahn, Sang Baie Shin, Tae Yeon Kim
  • Publication number: 20230122688
    Abstract: The present invention relates to a biocompatible polydopamine nanomotor capable of infiltrating a bladder wall in a biological environment and remaining inside a bladder for a long time.
    Type: Application
    Filed: March 10, 2020
    Publication date: April 20, 2023
    Inventors: Sei Kwang HAHN, Hyun Sik CHOI, Sang Baie SHIN
  • Publication number: 20220386863
    Abstract: The present invention relates to a contact lens for diagnosis and treatment of dry eye syndrome. The contact lens, according to the present invention, may diagnose dry eye syndrome by means of a change in an electric current occurring as a result of a field effect when a dry eye syndrome biomarker binds to a probe, and when dry eye syndrome is diagnosed, generates an electric current so that a gold film blocking a drug reservoir melts by the electric current, thereby enabling the release of a drug to be controlled.
    Type: Application
    Filed: February 24, 2021
    Publication date: December 8, 2022
    Inventors: Sei Kwang Hahn, Sang Baie Shin, Jong Hwan Mun, Tae Yeon Kim
  • Publication number: 20220323780
    Abstract: The present invention relates to a system for corneal crosslinking of injured corneas, treating keratoconus, or correcting vision, the system comprising: a hyaluronic acid-dye conjugate; and a contact lens including an LED light source. In the present invention, a dye is activated by receiving light irradiated from the LED light source of the contact lens so as to generate radicals, thereby generating a covalent bond between amino acid radicals of corneal collagen, and strengthening a collagen layer. In the present invention, the hyaluronic acid-dye conjugate, in which hyaluronic acid is bound to the dye, is used to improve penetration of the dye in the cornea, and the contact lens is used together with the hyaluronic acid-dye conjugate to further improve the penetration of the dye. In addition, the structure of the lens which presses the center of the cornea deforms the shape of the cornea, thereby having a vision correction effect.
    Type: Application
    Filed: September 11, 2020
    Publication date: October 13, 2022
    Inventors: Sei Kwang Hahn, Sang Baie Shin, Jong Hwan Mun
  • Publication number: 20210146135
    Abstract: The present invention relates to an electroceutical system for driving a photoelectric element implanted in a sub-retinal optic nerve using a smart photonic lens. According to the present invention, by artificially emitting the light of the smart photonic lens to a photoelectric element connected to the optic nerve, it is possible to utilize stimulation of the nerve with an electric current generated in the photoelectric element to treat various diseases.
    Type: Application
    Filed: November 28, 2019
    Publication date: May 20, 2021
    Inventors: Sei Kwang HAHN, Sang Baie Shin